Cite
HARVARD Citation
Burmester, G. et al. (2014). A randomised, double-blind, parallel-group study of the safety and efficacy of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional disease-modifying antirheumatic drugs in patients with moderate to severe rheumatoid arthritis (SUMMACTA study). Annals of the rheumatic diseases. 73 (1), pp. 69-74. [Online].